Joseph Maakaron, MD

Articles by Joseph Maakaron, MD

Joseph Maakaron, MD, assistant professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School

Dr Maakaron on Choosing Between Bispecific Antibodies and CAR T-Cell Therapy in DLBCL

ByJoseph Maakaron, MD

June 27th 2024

Joseph Maakaron, MD, discusses factors that influence his decision to use bispecific antibodies or CAR T-cell therapy in patients with DLBCL.

Latest Updated Articles

Trending on OncLive

Breaking Down Key Lung Cancer Data at ESMO 2026 With Drs Santos and Halmos

FDA Receives BLA for Etentamig in R/R Multiple Myeloma

T-DXd Gains EU Approval in Residual HER2+ Early Breast Cancer

Basser Center for BRCA Awards 2026 Global Prize to Judy Garber

Elranatamab Meets Phase 3 PFS End Point in R/R Myeloma After Anti-CD38 Therapy and Lenalidomide